Gehan Botrus

Infigratinib (BGJ398): an investigational agent for the treatment of FGFR-altered intrahepatic cholangiocarcinoma

Gehan Botrus, Puneet Raman, Thomas Oliver et al. · Expert Opinion on Investigational Drugs · 2020 · 51 citations

Medicine, Oncology, Pharmacology +16

Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma

Gehan Botrus, Heidi Kosirorek, Mohamad Bassam Sonbol et al. · The Oncologist · 2021 · 37 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis

Pedro Luiz Serrano Usón, Leonardo Carvalho, Milena Lourenço Coleta Fernandes et al. · Scientific Reports · 2022 · 22 citations · Full text

Medicine, Oncology, Surgery +14

Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy

Pedro Luiz Serrano Usón, Umair Majeed, Jun Yin et al. · JCO Precision Oncology · 2022 · 21 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Cutaneous aneurysmal fibrous histiocytoma with a t(12;19)(p12;q13) as the sole cytogenetic anomaly

Gehan Botrus, Raf Sciot, Maria Dêbiec‐Rychter · Cancer Genetics and Cytogenetics · 2006 · 20 citations

Medicine, Dermatology, Pathology +12